Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine
Status:
Recruiting
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
This study is an observational study on the efficacy and safety of auto-HSCT in adult
patients with Burkitt lymphoma, lymphoblastic lymphoma, and acute lymphoblastic leukemia who
received TCCA conditioning regimen. The study plans to include 28 patients who received the
TCCA regimen for pre-transplantation pretreatment before auto-HSCT. Maintenance treatment
will be carried out after transplantation for 1 year to observe the efficacy and safety.